GSK
GSK plc
Stock
$47.03−0.15 (−0.32%)Close Oct 2, 2026
- Selling, general and administrative, FY2025
- £9.1B
- YoY, FY2025
- −17.5%
- 5-year CAGR
- +4.1%
- 10-year CAGR
- −0.2%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| FY2025 | £9.1B | −17.5% |
| FY2024 | £11.0B | +17.4% |
| FY2023 | £9.4B | +12.1% |
| FY2022 | £8.4B | +18.4% |
| FY2021 | £7.1B | −4.9% |
| FY2020 | £7.4B | −34.8% |
| FY2019 | £11.4B | +15.0% |
| FY2018 | £9.9B | +2.5% |
| FY2017 | £9.7B | +3.3% |
| FY2016 | £9.4B | +1.5% |
| FY2015 | £9.2B | — |